PREVALENCE OF BRCA1 AND BRCA2 MUTATIONS IN WOMEN WITH EARLY-ONSET BREAST CANCER

Irfan Ishaque, Syed Gufran Sadiq Zaidi, Amna Noor, Tahir Hafeez, Ariba Shah, Roha Tariq, Shagufta Rasool, Syeda Neha Zainab

2025

Full text Open access: Hybrid Metadata (CSL-JSON)
DOI 10.71000/d1xdm317
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Background: Early-onset breast cancer poses significant clinical challenges due to its aggressive behavior and genetic predisposition. Mutations in the BRCA1 and BRCA2 genes are strongly linked to hereditary breast cancer, especially in younger patients. However, regional data on their prevalence remains limited in South Asian populations, particularly in Pakistan. Objective: To determine the prevalence of BRCA1 and BRCA2 gene mutations among women diagnosed with early-onset breast cancer in the Lahore region of Pakistan. Methods: A cross-sectional study was conducted over eight months involving 200 women aged ≤39 years with histologically confirmed breast cancer. Participants were recruited from three major oncology centers in Lahore. Clinical and demographic data were collected through structured interviews. Peripheral blood samples were analyzed using next-generation sequencing (NGS) for BRCA1/2 mutations. Statistical analysis was performed using SPSS v26, with significance set at p<0.05. Results: BRCA1 mutations were identified in 24 patients (12%) and BRCA2 mutations in 18 (9%). Variants of uncertain significance were found in 6 patients (3%), while 152 (76%) tested negative for both mutations. Mutation prevalence was significantly higher in patients with a family history of breast or ovarian cancer and among those with triple-negative breast cancer. BRCA1 mutations were most common in triple-negative cases (25%), while BRCA2 mutations showed a slightly more even distribution across subtypes. Conclusion: A considerable proportion of early-onset breast cancer patients in Pakistan carry BRCA mutations. These findings underscore the importance of routine genetic screening and tailored risk management strategies in young breast cancer patients, irrespective of family history.